The safety of hydroxyethyl starch use in newborns and its short- and long-term benefits in hypovolemic patients *
Author:
- George SimbrunerGSGeorge Simbruner
- 1 July 2003
- journal article
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
- Vol. 4 (3) , 388
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Plasma volume expansion by medium molecular weight hydroxyethyl starch in neonates: A pilot study*Pediatric Critical Care Medicine, 2003
- Plasma vascular endothelial growth factor level is a predictor of the severity of postoperative capillary leak syndrome in neonates undergoing cardiopulmonary bypassPediatric Surgery International, 2002
- An international view of hydroxyethyl starchesIntensive Care Medicine, 1999
- Excess mortality after human albumin administration in critically ill patientsBMJ, 1998
- Cochrane Injuries Group Albumin ReviewersWhy albumin may not workBMJ, 1998
- Multisystem organ failure and capillary leak syndrome in severe necrotizing enterocolitis of very low birth weight infantsJournal of Pediatric Surgery, 1998
- Pharmacology and physiology of colloidsBlood Reviews, 1993